Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
The peptide is one of two skin remodeling substances that may be able to downregulate the expression of metastatic genes
Many patients report reduced inflammation and early improvement in soreness within the first 5 to 14 days
Refrigeration recommended after opening
(4)(semaglutide)pH7.4 (semaglutide): 4.8 mg/ml ()() 8 mM(1.42 mg/ml)18.5 mg/ml 15 mM(2.67 mg/ml)17.5 mg/ml 20 mM (3.56 mg/ml)17.0 mg/ml 20 mM (3.56 mg/ml)7.60 mg/ml (HCl)pH7.4 (NaOH)pH7.4 (WFI)A total of four (4) semaglutide formulations were prepared, with various phosphate concentrations at pH 7.4, and the following composition: Semaglutide: 4.8 mg/ml Phosphate (buffer), and propylene glycol or sodium chloride as one of the following combinations of isotonic agents (the concentration of isotonic agent is adjusted according to the phosphate concentration to obtain an approximate isotonic formula): 8 mM phosphate (added as 1.42 mg/ml disodium hydrogen phosphate dihydrate) and 18.5 mg/ml propylene glycol 15 mM phosphate (added as 2.67 mg/ml disodium hydrogen phosphate dihydrate) and 17.5 mg/ml propylene glycol 20 mM phosphate (added as 3.56 mg/ml disodium hydrogen phosphate dihydrate) and 17.0 mg/ml propylene glycol 20 mM phosphate (added as 3.56 mg/ml disodium hydrogen phosphate dihydrate) and 7.60 mg/ml sodium chloride Hydrochloric acid (HCl), add as needed to obtain a pH of 7.4 Sodium hydroxide (NaOH), add as needed to obtain a pH of 7.4 Water for injection (WFI) is used as a solvent
US$ 23.54
US$ 25.06
US$ 21.50
US$ 27.84
US$ 28.31
US$ 23.44
US$ 25.75
